3EML

WisdomTree Emerging Markets 3x Daily Leveraged

ETFs & Funds · USD · LSE

3EMLETFT212

Price

$212.275

+1.32%

Cap

Earnings

30d Trend

+21.3%

3EML
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

82% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level80
Quality50
Momentum84
Technical58
Fundamentals50

Raw weighted: 61×Macro 0.99 (1%)=60

RISK

80/100
90d Volatility
82.0%High
ATR %
5.4%High daily moves
Max Drawdown (1Y)
-37.0%Volatile

QUALITY

50/100

MOMENTUM

84/100
12-1M Momentum
+152.4%Strong uptrend
6-1M Momentum
+53.7%Positive
1M Return
+25.4%Strong recent gains

TECHNICAL

58/100
RSI (14)
62.5Neutral
Price vs SMA200
+53.9%Bullish trend
MACD
-0.18Bearish momentum
Bollinger Band
82%Near upper band
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.205Noisy/choppy

FUNDAMENTALS

50/100

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 60%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months62
3-12 months84
1-5+ years50

6-9 month momentum thesis — strong trend with confirmation

BRAIN47'S ASSESSMENT

I rate WisdomTree Emerging Markets 3x Daily Leveraged at 60/100 — a STRONG reading on the Brain47 Signal. The strongest factor is momentum at 84/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

PAST PERFORMANCE

1 MONTH

+25.4%

3 MONTHS

+17.9%

12 MONTHS

+177.8%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

6-9 month momentum thesis — strong trend with confirmation. Momentum (84) and Technical (58) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 82%. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.

growthScore: 60/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.